ACOs and value-based care in 2024: Four key questions and answers

ACOs have long been at the front lines of value-based care efforts. In a recent LinkedIn Fireside Chat, Andy Dé sat down with David Bartley and Brian Norris to discuss how critical ACOs are to the success of value-based care, and what role the current healthcare environment is playing in that relationship.

1: How are accountable care organizations (ACOs) a part of the value-based care picture?

ACOs are groups of providers who collaborate to coordinate high-quality care for Medicare patients. They are well-positioned to optimize care delivery and reduce costs—two major goals of value-based care—and have been highly influential in the development of value-based arrangements. We are still in a period of experimentation with ACOs, however, continuously testing out various models and collecting comprehensive data on their outcomes. Recently, CMS reported that the Next Generation ACO Model (2016 to 2021) yielded a 1.9% reduction in spend (~$270 per member per year). We expect to see several more models emerge in the coming years as the transition from fee-for-service to value continues, each building on the shortcomings and successes of the previous iterations to create greater well-being across diverse communities.

2: What role does data play in ACO success within value-based care?

In reflecting on the performance of the Next Generation ACO Model mentioned above, over 66% of groups described gains in data analytic capacity as the most significant change they had undergone over the course of the model. In value-based care, that advanced capacity is crucial for successful collaboration and alignment across involved entities. Strong, flexible analytics is the basis for strategic, scalable action and measurable outcome improvement.

3:  For ACOs, what are the implications of value-driven initiatives around health equity and regulatory changes regarding social determinants of health?

From our perspective, changing expectations and regulations mean that now ACOs are actually more incentivized to focus resources on underserved communities. First, CMS is paying providers to do social determinants-based assessments twice a year. Second, payers are collecting more robust population data to construct better value-based networks. Third, organizations outside of healthcare are eager to be involved in improving health equity (e.g., Uber partnering with care organizations to get patients to appointments).

4: How are successful ACOs integrating technology into their value-based care strategy?

When ACOs adopt innovative, flexible tools, they’re better equipped to adapt to regulatory changes and make big strides in value-based care efforts. Interoperable, secure platforms for integrating and analyzing patient clinical and claims data are a huge asset to ACOs, as are AI-enabled capabilities for managing revenue cycle and building strong care networks. In short, there are a lot of pieces in a value-based care puzzle. Technology helps fit them together.

For more, watch the Fireside Chat below to hear more from our experts and glean key insights for your value-based care strategy.

Want to see more on how MedeAnalytics can help your ACO advance value-based initiatives this year? Let’s chat!

Editorial Team

MedeAnalytics is a leader in healthcare analytics, providing innovative solutions that enable measurable impact for healthcare payers and providers. With the most advanced data orchestration in healthcare, payers and providers count on us to deliver actionable insights that improve financial, operational, and clinical outcomes. To date, we’ve helped uncover millions of dollars in savings annually.

Get our take on industry trends

Using data analytics to combat the maternal health crisis

November 18, 2022

With most pregnancy-related deaths being considered preventable, why is the United States facing a maternal health crisis? The country’s maternal mortality rate is the highest of any developed nation in the world and more than double the rate of peer countries.

Read on...
Dr. Lyle Berkowitz

Q&A with Dr. Lyle Berkowitz: Diving into the future of AI, analytics and precision medicine

October 21, 2022

Estimated reading time: 4 minutes After an excellent keynote session led by Dr. Lyle Berkowitz at our 2022 Impact Summit…

Read on...
The missing piece to your Population Health strategy:

The missing piece to your Population Health strategy: A prescription for maximizing pharmacy data 

October 20, 2022

The healthcare industry is swimming in data; sometimes organizations can even feel like they are drowning in available information. To…

Read on...
Dr. Lyle Berkowitz

Data, analytics and AI-enabled healthcare: Four key takeaways from the IS22 keynote

October 18, 2022

The 2022 Impact Summit (IS22) was outstanding for a plethora of reasons—and Dr. Lyle Berkowitz is foremost among them. For this year’s keynote, Lyle…

Read on...